| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $18.0M | +5.6% |
| SG&A Expense | $9.7M | +0.9% |
| Operating Income | -$27.6M | -3.9% |
| Income Tax | $0 | — |
| Net Income | -$27.3M | -4.5% |
| EPS (Basic) | -$6.02 | -2.2% |
| EPS (Diluted) | -$6.02 | -2.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.2M | +44.3% |
| Current Assets | $21.9M | -54.6% |
| Total Assets | $22.0M | -54.6% |
| Current Liabilities | $3.4M | -24.9% |
| Total Liabilities | $3.4M | -26.1% |
| Stockholders' Equity | $18.6M | -57.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.9M | -4.7% |
| Capital Expenditures | $157K | +0.0% |
| Investing Cash Flow | $26.5M | +173.7% |
| Financing Cash Flow | $55.7M | +0.0% |
| Free Cash Flow | -$25.0M | -4.6% |